Harmony Biosciences Holdings, Inc. Quarterly Return On Equity in % from Q4 2020 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Harmony Biosciences Holdings, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2020 to Q3 2024.
  • Harmony Biosciences Holdings, Inc. Return On Equity for the quarter ending September 30, 2024 was 23.2 %, a 30.4% decline year-over-year.
  • Harmony Biosciences Holdings, Inc. annual Return On Equity for 2023 was 27.5 %, a 54.3% decline from 2022.
  • Harmony Biosciences Holdings, Inc. annual Return On Equity for 2022 was 60.1 %, a 149% increase from 2021.
  • Harmony Biosciences Holdings, Inc. annual Return On Equity for 2021 was 24.2 %, a 24.9% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 23.2 -10.1 -30.4% Jul 1, 2024 Sep 30, 2024
Q2 2024 23 -24.9 -52% Apr 1, 2024 Jun 30, 2024
Q1 2024 28.3 -24.5 -46.4% Jan 1, 2024 Mar 31, 2024
Q4 2023 27.5 -32.6 -54.3% Oct 1, 2023 Dec 31, 2023
Q3 2023 33.3 -29.5 -47% Jul 1, 2023 Sep 30, 2023
Q2 2023 47.8 +18.8 +64.5% Apr 1, 2023 Jun 30, 2023
Q1 2023 52.8 +24.1 +84.1% Jan 1, 2023 Mar 31, 2023
Q4 2022 60.1 +36 +149% Oct 1, 2022 Dec 31, 2022
Q3 2022 62.8 +53.2 +550% Jul 1, 2022 Sep 30, 2022
Q2 2022 29.1 +7.29 +33.5% Apr 1, 2022 Jun 30, 2022
Q1 2022 28.7 +48.4 Jan 1, 2022 Mar 31, 2022
Q4 2021 24.2 +4.81 +24.9% Oct 1, 2021 Dec 31, 2021
Q3 2021 9.66 Jul 1, 2021 Sep 30, 2021
Q2 2021 21.8 Apr 1, 2021 Jun 30, 2021
Q1 2021 -19.7 Jan 1, 2021 Mar 31, 2021
Q4 2020 19.3 Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.